Broncus Holding Corporation (2216.HK) — Stock Score Summary

Broncus Holding Corporation (2216.HK) has a MoatMap StockRank of 32/100 based on Quality (52/100), Value (45/100), and Momentum (23/100) factor scores. The current signal is SELL. Broncus Holding is a micro-cap medical device company focused on interventional pulmonology. It is unprofitable, highly speculative, and lacks any connection to our core macro themes or the quality metrics required by our investment philosophy.

Broncus Holding Corporation is a pioneer in interventional pulmonology, developing navigation systems, diagnostic consumables, and therapeutic devices for lung diseases. The company's integrated platform enables precise navigation and targeted treatment of lung cancer and COPD. Its competitive advantage is secured by a robust global patent portfolio and first-mover status in the Chinese interventional pulmonology market.

Key Financial Metrics

Price$0.10
Market Cap$67M
Price/Book0.36
Return on Equity-11.2%
Return on Invested Capital-9.0%
Debt/Equity0.01
Gross Margin0.0%
Operating Margin818.0%
Free Cash Flow$-148K

Broncus Holding Corporation operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Broncus Holding Corporation’s (2216.HK) StockRank?
MoatMap’s StockRank for Broncus Holding Corporation (2216.HK) is 32/100, with a Sell signal. It is a composite of Quality (52), Value (45), and Momentum (23) factor ranks across MoatMap’s 19,000+ stock universe.
Does Broncus Holding Corporation have an economic moat?
Broncus Holding Corporation (2216.HK) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Broncus Holding Corporation a buy, hold, or sell?
MoatMap’s current signal for Broncus Holding Corporation (2216.HK) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Broncus Holding Corporation in?
Broncus Holding Corporation (2216.HK) operates in the Healthcare sector, specifically the Medical Devices industry (China).
Browse all ranked stocks2216.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock